Whistleblower Claims Over Lipitor Marketing Tossed

A federal judge has dismissed whistleblower claims filed by a former medical director at Pfizer Inc. over the company's alleged off-label marketing of its statin Lipitor, but has allowed the doctor's...

Already a subscriber? Click here to view full article